UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Common osteoporosis drug associated with increased rates of depression and anxiety

Scientific reports, 2021-12, Vol.11 (1), p.23956-23956, Article 23956

2021

Volltextzugriff (PDF)

A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients

Scientific reports, 2022-05, Vol.12 (1), p.8641-8641, Article 8641

2022

Volltextzugriff (PDF)

Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system

Scientific reports, 2023-07, Vol.13 (1), p.10892-10892, Article 10892

2023

Volltextzugriff (PDF)

Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study

Scientific reports, 2023-08, Vol.13 (1), p.12890-12890, Article 12890

2023

Volltextzugriff (PDF)

Differences in femur geometry and bone markers in atypical femur fractures and the general population

Scientific reports, 2021-12, Vol.11 (1), p.24149-24149, Article 24149

2021

Volltextzugriff (PDF)

Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw

Scientific reports, 2024-04, Vol.14 (1), p.8744-8744, Article 8744

2024

Volltextzugriff (PDF)

Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid

Scientific reports, 2019-06, Vol.9 (1), p.8310, Article 8310

2019

Volltextzugriff (PDF)

Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics

Scientific reports, 2022-01, Vol.12 (1), p.19-13, Article 19

2022

Volltextzugriff (PDF)

Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw

Scientific reports, 2024-04, Vol.14 (1), p.7914-7914, Article 7914

2024

Volltextzugriff (PDF)

Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review

Nature reviews. Endocrinology, 2011-01, Vol.7 (1), p.34-42

2011

Volltextzugriff (PDF)

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

British journal of cancer, 2004-03, Vol.90 (6), p.1133-1137

2004

Volltextzugriff (PDF)

Pre-existing medication-related osteonecrosis of the jaw before dental extraction

British dental journal, 2023-11, Vol.235 (10), p.783-788

2023

Volltextzugriff (PDF)

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

British journal of cancer, 2012-11, Vol.107 (10), p.1665-1671

2012

Volltextzugriff (PDF)

Risks and benefits of bisphosphonates

British journal of cancer, 2008-06, Vol.98 (11), p.1736-1740

COLEMAN, R. E

2008

Volltextzugriff (PDF)

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial

Blood cancer journal (New York), 2016-01, Vol.6 (1), p.e378-e378

2016

Volltextzugriff (PDF)

Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature

British dental journal, 2020-06, Vol.228 (11), p.886-892

2020

Volltextzugriff (PDF)

Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease

Nature clinical practice. Oncology, 2007-01, Vol.4 (1), p.42-55

2007

Volltextzugriff (PDF)

Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis

Prostate cancer and prostatic diseases, 2012-03, Vol.15 (1), p.36-44

2012

Volltextzugriff (PDF)

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases : a randomised, crossover study of community vs hospital bisphosphonate administration

British journal of cancer, 2005-05, Vol.92 (10), p.1869-1876

2005

Volltextzugriff (PDF)

Bisphosphonates as antimyeloma drugs

Leukemia, 2012-04, Vol.26 (4), p.589-594

2012

Volltextzugriff (PDF)

Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma

Bone marrow transplantation (Basingstoke), 2015-01, Vol.50 (1), p.157-157

2015

Volltextzugriff (PDF)

Intravenous bisphosphonate therapy and atrial fibrillation flutter risk in cancer patients: a nationwide cohort study

British journal of cancer, 2011-09, Vol.105 (7), p.881-883

2011

Volltextzugriff (PDF)

Bone Use of bisphosphonates in children-proceed with caution

Nature reviews. Endocrinology, 2009-05, Vol.5 (5), p.241-243

Marini, Joan C

2009

Volltextzugriff (PDF)

A Single Dose of Intravenous Zoledronate Prevents Glucocorticoid Therapy-Associated Bone Loss in Acute Flare of Crohn's Disease, a Randomized Controlled Trial

The American journal of gastroenterology, 2011-04, Vol.106 (4), p.786-793

2011

Volltextzugriff (PDF)

Managing patients on bisphosphonates: the practice of primary care dentists before and after the publication of national guidance

British dental journal, 2014-12, Vol.217 (12), p.E25-E25

2014

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

KollektionNature Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(72)

Publikationsform

Artikel
(85)

Sprache

Englisch
(85)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(83)
Science & Technology
(81)
Life Sciences & Biomedicine
(69)
Diphosphonates - Adverse Effects
(63)
Bone Density Conservation Agents - Adverse Effects
(38)
Bisphosphonates
(34)
Diphosphonates - Therapeutic Use
(32)
Female
(29)
Dentistry
(28)
Dentistry, Oral Surgery & Medicine
(28)
Osteoporosis
(28)
Male
(25)
Oncology
(24)
Aged
(22)
Middle Aged
(21)
Osteonecrosis - Chemically Induced
(21)
Diphosphonates - Administration & Dosage
(18)
Fractures
(17)
Jaw
(16)
Bone Density Conservation Agent
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Common osteoporosis drug associated with increased rates of depression and anxiety

A 5-year retrospective cohort study of denosumab induced medication related osteonecrosis of the jaw in osteoporosis patients

Atypical femur fracture associated with common anti-osteoporosis drugs in FDA adverse event reporting system

Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: a retrospective and observational study

Differences in femur geometry and bone markers in atypical femur fractures and the general population

Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw

Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid

Osteonecrosis development by tooth extraction in zoledronate treated mice is inhibited by active vitamin D analogues, anti-inflammatory agents or antibiotics

Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw

Osteonecrosis of the jaw and bisphosphonates in cancer: a narrative review

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

Pre-existing medication-related osteonecrosis of the jaw before dental extraction

Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases

Risks and benefits of bisphosphonates

Evaluating results from the multiple myeloma patient subset treated with denosumab or zoledronic acid in a randomized phase 3 trial

Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature

Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease

Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis

Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases : a randomised, crossover study of community vs hospital bisphosphonate administration

Bisphosphonates as antimyeloma drugs

Bisphosphonates do not delay engraftment after autologous SCT in patients with newly diagnosed myeloma

Intravenous bisphosphonate therapy and atrial fibrillation flutter risk in cancer patients: a nationwide cohort study

Bone Use of bisphosphonates in children-proceed with caution

A Single Dose of Intravenous Zoledronate Prevents Glucocorticoid Therapy-Associated Bone Loss in Acute Flare of Crohn's Disease, a Randomized Controlled Trial

Managing patients on bisphosphonates: the practice of primary care dentists before and after the publication of national guidance

Aktive Filter

Suchergebnisse filtern